Xvivo Perfusion AB (OTCPK:XVIPF)
$ 42.9 1.67 (4.05%) Market Cap: 1.41 Bil Enterprise Value: 1.34 Bil PE Ratio: 67.14 PB Ratio: 7.03 GF Score: 86/100

Q1 2023 Xvivo Perfusion AB Earnings Call Transcript

Apr 24, 2023 / 12:00PM GMT
Release Date Price: $22.7
Operator

Welcome to XVIVO Q1 Report for 2023. (Operator Instructions) Now I will hand the conference over to CEO, Christoffer Rosenblad and CFO, Kristoffer Nordstrom. Please go ahead.

Christoffer Rosenblad;publ;CEO
Xvivo Perfusion AB

()-

Thank you so much, and welcome to XVIVO's earnings call for the first quarter of 2023. Today's presenters are myself, Christoffer Rosenblad, CEO for XVIVO and Kristoffer Nordstrom, CFO. On Slide 3, you can see the financials at a glance, and I'm very happy and proud to report that Q1 was the strongest quarter ever posted by XVIVO. We saw sales of SEK 141 million, organic growth of 34% and an adjusted EBITDA of 18%. And we're also very pleased to see continued high organic constant currency growth and improving gross margin for disposable products for all segments. Also, contain that the integration of our 3 last latest acquisition has progressed according to plan, and they have significantly contributed to the high growth during the quarter. An opportunity to further integrate the STAR recovery service

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot